Bought $16k of stock last few weeks. Link in bio for free value stock analysis checklist that I use
3 extracted signals · 0 resolved · 3 still active
Smart X CapitalIndependent analyst profile- Source published
- 11 Aug 2026, 02:01 UTC
- Recorded by Tahlil Plus
- 11 Aug 2026, 03:16 UTC

AI-generated source summary
The analysis focuses on four tech stocks: Microsoft (MSFT), Nvidia (NVDA), Meta (META), and ResMed (RMD). All stocks are currently in a bearish trend, having experienced significant drops, with MSFT trading around $378, NVDA near $190, META at $587.94, and RMD at $223.14. The reasoning for investment is primarily fundamental, highlighting strong past performance, growth potential, and attractive valuations following recent price declines. Microsoft's investment is justified by its robust ecosystem (Office, Azure) and AI initiatives, with a target price of $450 and a fail bound at $350. Nvidia is favored for its dominant position in AI chips, with a target of $240 and a fail bound at $170. Meta's investment is based on its strong ad revenue, significant AI investment, and a P/E ratio below industry average, targeting $700 with a fail bound at $500. ResMed is considered a value play due to its strong financial health and growth potential from weight-loss drug side effects, with a target of $280 and a fail bound at $200. The overall market sentiment is cautiously optimistic, anticipating a rebound in these fundamentally sound growth stocks from their current lows.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
3 signals remain active.
Smart X Capital
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.


